April 22, 2026 Overcoming Resistance and RevMed’s Next Drug: RM-055 as a Catalytic Inhibitor in the RAS Inhibitor Arms Race
April 21, 2026 UnitedHealth Q1 Earnings Beat, Raises Profit Outlook Amid AI Investment and Medicare Cost Pressures
